2017 Q4 Form 10-Q Financial Statement
#000143774918002157 Filed on February 09, 2018
Income Statement
| Concept | 2017 Q4 | 2016 Q4 |
|---|---|---|
| Revenue | $1.536M | $1.028M |
| YoY Change | 49.42% | -13.54% |
| Cost Of Revenue | $1.005M | $1.029M |
| YoY Change | -2.33% | -11.45% |
| Gross Profit | $531.0K | -$1.000K |
| YoY Change | -53200.0% | -103.33% |
| Gross Profit Margin | 34.57% | -0.1% |
| Selling, General & Admin | $1.659M | $1.376M |
| YoY Change | 20.57% | -0.22% |
| % of Gross Profit | 312.43% | |
| Research & Development | $340.0K | $150.0K |
| YoY Change | 126.67% | 158.62% |
| % of Gross Profit | 64.03% | |
| Depreciation & Amortization | $40.00K | $20.00K |
| YoY Change | 100.0% | -85.46% |
| % of Gross Profit | 7.53% | |
| Operating Expenses | $1.999M | $1.478M |
| YoY Change | 35.25% | 2.85% |
| Operating Profit | -$1.468M | -$1.479M |
| YoY Change | -0.74% | 4.89% |
| Interest Expense | $10.00K | $30.00K |
| YoY Change | -66.67% | |
| % of Operating Profit | ||
| Other Income/Expense, Net | $5.000K | $29.00K |
| YoY Change | -82.76% | -70.71% |
| Pretax Income | -$1.460M | -$1.450M |
| YoY Change | 0.69% | 10.69% |
| Income Tax | ||
| % Of Pretax Income | ||
| Net Earnings | -$1.463M | -$1.450M |
| YoY Change | 0.9% | 10.52% |
| Net Earnings / Revenue | -95.25% | -141.05% |
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$26.52K | -$26.35K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 55.02M shares | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2017 Q4 | 2016 Q4 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $5.680M | $11.95M |
| YoY Change | -52.47% | -5.16% |
| Cash & Equivalents | $2.951M | $6.668M |
| Short-Term Investments | $2.730M | $5.280M |
| Other Short-Term Assets | $300.0K | $220.0K |
| YoY Change | 36.36% | 0.0% |
| Inventory | $459.0K | $380.0K |
| Prepaid Expenses | ||
| Receivables | $990.0K | $630.0K |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $7.417M | $13.18M |
| YoY Change | -43.72% | -7.73% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $1.168M | $779.0K |
| YoY Change | 49.94% | 132.02% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | $0.00 | |
| YoY Change | -100.0% | |
| Other Assets | $204.0K | $278.0K |
| YoY Change | -26.62% | 19.31% |
| Total Long-Term Assets | $1.961M | $1.806M |
| YoY Change | 8.58% | -72.05% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $7.417M | $13.18M |
| Total Long-Term Assets | $1.961M | $1.806M |
| Total Assets | $9.378M | $14.99M |
| YoY Change | -37.42% | -27.76% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $580.0K | $310.0K |
| YoY Change | 87.1% | -54.41% |
| Accrued Expenses | $350.0K | $560.0K |
| YoY Change | -37.5% | 40.0% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $931.0K | $871.0K |
| YoY Change | 6.89% | -19.26% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $580.0K | $550.0K |
| YoY Change | 5.45% | -50.45% |
| Total Long-Term Liabilities | $580.0K | $550.0K |
| YoY Change | 5.45% | -50.45% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $931.0K | $871.0K |
| Total Long-Term Liabilities | $580.0K | $550.0K |
| Total Liabilities | $1.507M | $1.418M |
| YoY Change | 6.28% | -35.34% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$75.61M | -$69.39M |
| YoY Change | 8.97% | 8.32% |
| Common Stock | $83.49M | $82.96M |
| YoY Change | 0.64% | 0.4% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $7.871M | $13.57M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $9.378M | $14.99M |
| YoY Change | -37.42% | -27.76% |
Cashflow Statement
| Concept | 2017 Q4 | 2016 Q4 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$1.463M | -$1.450M |
| YoY Change | 0.9% | 10.52% |
| Depreciation, Depletion And Amortization | $40.00K | $20.00K |
| YoY Change | 100.0% | -85.46% |
| Cash From Operating Activities | -$1.520M | -$1.660M |
| YoY Change | -8.43% | 104.94% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$100.0K | -$90.00K |
| YoY Change | 11.11% | 200.0% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $570.0K | -$30.00K |
| YoY Change | -2000.0% | -40.0% |
| Cash From Investing Activities | $480.0K | -$120.0K |
| YoY Change | -500.0% | 50.0% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 40.00K | -10.00K |
| YoY Change | -500.0% | 0.0% |
| NET CHANGE | ||
| Cash From Operating Activities | -1.520M | -1.660M |
| Cash From Investing Activities | 480.0K | -120.0K |
| Cash From Financing Activities | 40.00K | -10.00K |
| Net Change In Cash | -1.000M | -1.790M |
| YoY Change | -44.13% | 98.89% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$1.520M | -$1.660M |
| Capital Expenditures | -$100.0K | -$90.00K |
| Free Cash Flow | -$1.420M | -$1.570M |
| YoY Change | -9.55% | 101.28% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| isr |
Class Of Warrant Or Right Issued For Services
ClassOfWarrantOrRightIssuedForServices
|
250000 | ||
| isr |
Class Of Warrant Or Right Issued For Services Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightIssuedForServicesWeightedAverageExercisePriceOfWarrantsOrRights
|
0.54 | ||
| CY2017Q4 | isr |
Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
|
29000 | |
| CY2016Q4 | isr |
Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
|
||
| isr |
Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
|
104000 | ||
| isr |
Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
|
|||
| CY2017Q4 | isr |
Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
|
311000 | |
| CY2016Q4 | isr |
Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
|
150000 | |
| isr |
Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
|
597000 | ||
| isr |
Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
|
322000 | ||
| CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
7627000 | |
| CY2017Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
7591000 | |
| CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
83430000 | |
| CY2017Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
83151000 | |
| us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
26000 | ||
| us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
23000 | ||
| CY2017Q4 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
78000 | |
| CY2016Q4 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
52000 | |
| CY2017Q4 | isr |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
|
0 | |
| CY2016Q4 | isr |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
|
4000 | |
| isr |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
|
33000 | ||
| isr |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
|
4000 | ||
| CY2017Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
581000 | |
| CY2017Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
630000 | |
| CY2017Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
43000 | |
| CY2017Q2 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
75000 | |
| CY2017Q4 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
123000 | |
| CY2017Q2 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
138000 | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
168000 | ||
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
122000 | ||
| CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
26000 | |
| CY2017Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
26000 | |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3604000 | ||
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2629000 | ||
| us-gaap |
Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
|
15000 | ||
| us-gaap |
Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
|
15000 | ||
| us-gaap |
Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
|
|||
| us-gaap |
Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
|
48000 | ||
| CY2017Q4 | us-gaap |
Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
|
||
| CY2016Q4 | us-gaap |
Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
|
48000 | |
| CY2017Q4 | us-gaap |
Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
|
576000 | |
| CY2017Q2 | us-gaap |
Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
|
561000 | |
| CY2017Q4 | us-gaap |
Assets
Assets
|
9378000 | |
| CY2017Q2 | us-gaap |
Assets
Assets
|
12269000 | |
| CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
7417000 | |
| CY2017Q2 | us-gaap |
Assets Current
AssetsCurrent
|
10291000 | |
| CY2017Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5932000 | |
| CY2016Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
10139000 | |
| CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2951000 | |
| CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
6668000 | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-2981000 | ||
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-3471000 | ||
| CY2017Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.54 | |
| CY2017Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
||
| CY2017Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
250000 | |
| CY2017Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
||
| CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2017Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
192998329 | |
| CY2017Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
192998329 | |
| CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
55100229 | |
| CY2017Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
55017419 | |
| CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
55100229 | |
| CY2017Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
55017419 | |
| CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
55000 | |
| CY2017Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
55000 | |
| CY2017Q4 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
1005000 | |
| CY2016Q4 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
1029000 | |
| us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
1951000 | ||
| us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
2062000 | ||
| us-gaap |
Depreciation
Depreciation
|
36000 | ||
| us-gaap |
Depreciation
Depreciation
|
32000 | ||
| us-gaap |
Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: top;"> <td style="width: 54pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></div></div> </td> <td> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">New Accounting Pronouncements</div></div> </td> </tr> </table> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> Revenue Recognition, replacing guidance currently codified in Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> Revenue Recognition-Overall with various SEC Staff Accounting Bulletins providing interpretive guidance. The guidance establishes a new <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> step principle-based framework in an effort to significantly enhance comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets. The standard will be effective for the Company in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of its fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> but early adoption is permitted starting in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> The Company intends to adopt the new standard in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and expects to use the modified retrospective method. The Company has evaluated the impact of the future adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> on its consolidated financial statements and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> currently expect significant changes in the timing of revenue recognition compared to the existing methodology. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2015, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11:</div> Inventory. The guidance requires an entity<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">’s management to measure inventory within the scope of this ASU at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016. </div>Early application is permitted. The ASU became effective for the Company on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 1, 2017. </div>This update did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on the Company’s consolidated financial statements upon adoption.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 20</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> the FASB issued an ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div> to simplify the balance sheet classification of deferred taxes. This update requires all deferred tax assets and liabilities to be reported as non-current in the consolidated balance sheets. The ASU became effective for the Company on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 1, 2017. </div>This update did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> to have a material impact on the Company’s consolidated financial statements upon adoption.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> Leases (Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>), which will require lessees to recognize asset<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">s and liabilities on the balance sheet for the rights and obligations created by most leases. The update is effective for annual and interim reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018. </div>Early adoption is permitted. The ASU will be effective for the Company in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020.</div> We are currently evaluating the impact of the guidance on the Company’s consolidated financial statements.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Classificat<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">ion of Certain Cash Receipts and Cash Payments. The update provides guidance on classification for cash receipts and payments related to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> specific issues. The update is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>and interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of implementing this update on the consolidated financial statements.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Other accounting standards that have been issued or proposed by FASB that do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">t require adoption until a future date are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expected to have a material impact on the consolidated financial statements upon adoption. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> discuss recent pronouncements that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</div></div></div> | ||
| CY2017Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.03 | |
| CY2016Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.03 | |
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.05 | ||
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.05 | ||
| us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | ||
| CY2017Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
165000 | |
| CY2017Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
138000 | |
| CY2017Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
722000 | |
| us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y98D | ||
| us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
|||
| us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-5000 | ||
| CY2017Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
985000 | |
| CY2016Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
880000 | |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1827000 | ||
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1807000 | ||
| CY2017Q4 | us-gaap |
Gross Profit
GrossProfit
|
531000 | |
| CY2016Q4 | us-gaap |
Gross Profit
GrossProfit
|
-1000 | |
| us-gaap |
Gross Profit
GrossProfit
|
796000 | ||
| us-gaap |
Gross Profit
GrossProfit
|
47000 | ||
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-49000 | ||
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-299000 | ||
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
261000 | ||
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
22000 | ||
| us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
27000 | ||
| us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
18000 | ||
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
31000 | ||
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
24000 | ||
| us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
-32000 | ||
| us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
34000 | ||
| us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-106000 | ||
| us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
18000 | ||
| us-gaap |
Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
|
-15000 | ||
| us-gaap |
Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
|
7000 | ||
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
24000 | ||
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-79000 | ||
| CY2017Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
367000 | |
| CY2017Q2 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
191000 | |
| CY2017Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
82000 | |
| CY2017Q2 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
121000 | |
| CY2017Q4 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
5000 | |
| CY2016Q4 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
29000 | |
| us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
10000 | ||
| us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
60000 | ||
| CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
1507000 | |
| CY2017Q2 | us-gaap |
Liabilities
Liabilities
|
1667000 | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-2947000 | ||
| CY2017Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1463000 | |
| CY2017Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
10000 | |
| CY2017Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
11000 | |
| CY2017Q4 | us-gaap |
Inventory Net
InventoryNet
|
459000 | |
| CY2017Q2 | us-gaap |
Inventory Net
InventoryNet
|
323000 | |
| CY2017Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
408000 | |
| CY2017Q2 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
513000 | |
| CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
9378000 | |
| CY2017Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
12269000 | |
| CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
931000 | |
| CY2017Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1106000 | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
39000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-9000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
164000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-448000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3184000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3014000 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-3010000 | ||
| CY2016Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1450000 | |
| CY2017Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1466000 | |
| CY2016Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1452000 | |
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-3015000 | ||
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2952000 | ||
| CY2017Q4 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
5000 | |
| CY2016Q4 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
29000 | |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
10000 | ||
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
107000 | ||
| CY2017Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
1999000 | |
| CY2016Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
1478000 | |
| us-gaap |
Operating Expenses
OperatingExpenses
|
3816000 | ||
| us-gaap |
Operating Expenses
OperatingExpenses
|
3101000 | ||
| CY2017Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1468000 | |
| CY2016Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1479000 | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3020000 | ||
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3054000 | ||
| CY2017Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
230000 | |
| CY2017Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
19000 | |
| CY2017Q2 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
125000 | |
| CY2017Q4 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
||
| CY2016Q4 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
||
| CY2017Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
204000 | |
| us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
|||
| us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
20000 | ||
| us-gaap |
Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
|
11000 | ||
| us-gaap |
Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
|
11000 | ||
| us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
|||
| us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
151000 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
150000 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
239000 | ||
| us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
3554000 | ||
| us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
58000 | ||
| CY2017Q4 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
3000 | |
| CY2016Q4 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
2000 | |
| us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
5000 | ||
| us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
5000 | ||
| CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
7001671 | |
| CY2017Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
7001671 | |
| CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
295000 | |
| CY2017Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
271000 | |
| us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
3868000 | ||
| us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
|||
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
50000 | ||
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
2000 | ||
| CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
8795000 | |
| CY2017Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
8645000 | |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1168000 | |
| CY2017Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1054000 | |
| CY2017Q4 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
987000 | |
| CY2017Q2 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
726000 | |
| CY2017Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
340000 | |
| CY2016Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
150000 | |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
701000 | ||
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
322000 | ||
| CY2017Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
181000 | |
| CY2017Q2 | us-gaap |
Short Term Investments
ShortTermInvestments
|
3039000 | |
| CY2017Q4 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
82810 | |
| CY2016Q4 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
6800 | |
| us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
82810 | ||
| us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
6800 | ||
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
7871000 | |
| us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
2109000 | ||
| CY2017Q2 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
181000 | |
| CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-75614000 | |
| CY2017Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-72604000 | |
| CY2017Q4 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
1536000 | |
| CY2016Q4 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
1028000 | |
| us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
2747000 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
240000 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
122000 | ||
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1747000 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.91 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
3000 | |
| CY2017Q4 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
674000 | |
| CY2016Q4 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
496000 | |
| us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1288000 | ||
| us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1020000 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
3000 | ||
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
0 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
0 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
280534 | ||
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
0 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
16875 | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
47669 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
76541 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
83005 | ||
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
10000 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
75000 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
10000 | ||
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
36000 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3295000 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.76 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
36000 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
36000 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
3192000 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
0.76 | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y146D | ||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P5Y197D | ||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P7Y124D | ||
| CY2017Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
2725000 | |
| CY2017Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10602000 | |
| us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
|||
| us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
27000 | ||
| CY2017Q4 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
||
| CY2016Q4 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
||
| CY2017Q4 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
55056000 | |
| CY2016Q4 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
55017000 | |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
55037000 | ||
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
55014000 |
